Constantine Milathianakis

Combination of Somatostatin Analog, Dexamethasone, and Standard Androgen Ablation Therapy in Stage D3 Prostate Cancer Patients with Bone Metastases

Michael Koutsilieris, Constantine S. Mitsiades, John Bogdanos et al. · Clinical Cancer Research · 2004 · 52 citations · Full text

Molecular staging by RT-PCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer

Constantine S. Mitsiades, Peter Lembessis, Antigone Sourla et al. · Clinical & Experimental Metastasis · 2004 · 46 citations

Surgical Oncology, Urology, Perineural Invasion +10

Randomized controlled clinical trial of a combination of somatostatin analog and dexamethasone plus zoledronate vs. zoledronate in patients with androgen ablation-refractory prostate cancer.

Constantine S. Mitsiades, John Bogdanos, Dimitrios Karamanolakis et al. · PubMed · 2006 · 41 citations

Combined androgen blockade-induced anemia in prostate cancer patients without bone involvement.

John Bogdanos, Dimitrios Karamanolakis, Constantine Milathianakis et al. · PubMed · 2003 · 32 citations

Serum testosterone: A potentially adjunct screening test for the assessment of the risk of prostate cancer among men with modestly elevated PSA values (> or =3.0 and <10.0 ng/ml).

Dimitrios Karamanolakis, Theocharis Lambou, John Bogdanos et al. · PubMed · 2006 · 29 citations

Urogenital Radiology, Urology, Andrology +14